Tag
Analysts are projecting approximately 30% year-over-year growth for Boston Scientific (BSX) by 2026, driving bullish positioning on the stock. That growth rate, if realized, would significantly outperform the broader medical device peer group and support upward multiple expansion.
Analysts are forecasting roughly 80% upside in Rubrik stock, framing the cybersecurity firm as a potential beneficiary of Iran-related conflict risk. Elevated nation-state threat environments historically accelerate enterprise spending on data protection and ransomware recovery. The durability of the thesis depends on
Tag
Analysts are projecting approximately 30% year-over-year growth for Boston Scientific (BSX) by 2026, driving bullish positioning on the stock. That growth rate, if realized, would significantly outperform the broader medical device peer group and support upward multiple expansion.
2mo ago · 1 min · Markets
Analysts are forecasting roughly 80% upside in Rubrik stock, framing the cybersecurity firm as a potential beneficiary of Iran-related conflict risk. Elevated nation-state threat environments historically accelerate enterprise spending on data protection and ransomware recovery. The durability of the thesis depends on
2mo ago · 1 min · Markets
— End of feed —